SARS–CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges

SARS–CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a novel coronavirus that emerged from Wuhan, China in late 2019 causing coronavirus disease-19 (COVID-19). SARS-CoV-2 infection begins by attaching to angiotensin-converting enzyme 2 receptor (ACE2) via the spike glycoprotein, followed...

Full description

Bibliographic Details
Main Authors: Andrew R. McGill, Roukiah Khalil, Rinku Dutta, Ryan Green, Mark Howell, Subhra Mohapatra, Shyam S. Mohapatra
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Infectious Disease Reports
Subjects:
SARS-COV-2
COVID-19
immunopathogenesis
therapeutics
vaccines
Online Access:https://www.mdpi.com/2036-7449/13/1/13

Internet

https://www.mdpi.com/2036-7449/13/1/13

Similar Items